News and Trends


5,705 reads | 0 comments | 08/24/2011
Diabetes Care recently cited 11 risk factors that one could use to predict amputation in patients with diabetic foot infection. Lead study author Benjamin Lipsky, MD, notes the risk score includes findings from the history, physical examination or simple laboratory tests."> Given that lower extremity amputation is a devastating consequence of diabetic foot infection, physicians must be vigilant for the signs that could presage amputation. In a new study in Diabetes Care, authors have developed a risk score of 11 factors that could predict amputation. | Continue reading

5,226 reads | 0 comments | 07/25/2011
California podiatric physicians could eventually have the same license as their fellow physicians and surgeons from other disciplines. The California Podiatric Medical Association (CPMA) recently formed a task force with the California Medical Association and the California Orthopaedic Association to develop a plan for California’s podiatric medical schools to eventually attain accreditation as full-fledged allopathic medical schools. | Continue reading

5,351 reads | 0 comments | 06/21/2011
Neurology examine the efficacy of different modalities for painful diabetic neuropathy."> New evidence-based guidelines for painful diabetic neuropathy, recently published in Neurology, examine the efficacy of various types of modalities to relieve the pain of diabetic neuropathy. The authors note that pregabalin (Lyrica, Pfizer) is effective for Level A neuropathy while venlafaxine (Effexor, Pfizer), duloxetine (Cymbalta, Eli Lilly), amitriptyline (Elavil, Merck), gabapentin (Neurontin, Pfizer), valproate (Depacon, Abbott Laboratories), opioids and capsaicin are effective for Level B neuropathy. | Continue reading

9,640 reads | 0 comments | 05/18/2011
A recent study in the New England Journal of Medicine (NEJM) shows good results from the precautionary measures instituted in Veterans Affairs (VA) hospitals in 2007 to prevent the spread of methicillin resistant Staphylococcus aureus (MRSA). However, a second NEJM study suggests MRSA precautions are not effective in intensive care units (ICU). | Continue reading

7,113 reads | 0 comments | 04/21/2011
Study Finds Good Long-Term Results With First MPJ Implants By Brian McCurdy, Senior Editor A n abstract presented at the recent American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference notes good long-term results with a double-stem silicone first MPJ implant with titanium grommets. | Continue reading

14,264 reads | 0 comments | 03/22/2011
Investigating plantar fibromas as an etiology for recalcitrant heel pain, the authors of a recently published study suggest that 25 percent of recalcitrant heel pain is neoplastic in origin. The study authors also maintain that patients presenting with proximal plantar fibromas require excision and not fasciotomy. | Continue reading

5,420 reads | 1 comments | 02/23/2011
The number of Americans with diabetes continues to escalate. Approximately 25.8 million people have diabetes, about 8.3 percent of the United States population, according to new estimates from the Centers for Disease Control and Prevention (CDC). This is an increase of 2.2 million people since the last CDC estimates released in 2007. The new total includes 7 million people who are unaware that they have the disease. | Continue reading

6,627 reads | 0 comments | 01/27/2011
Recognizing the rise of methicillin resistant Staphylococcus aureus (MRSA) and its role in infections acquired in the hospital and community, the Infectious Diseases Society of America (IDSA) has released its first guidelines on treating MRSA. | Continue reading

10,278 reads | 0 comments | 12/28/2010
Are Silver Dressings Worth The Expense? By Brian McCurdy, Senior Editor While there are a fair number of wound dressings that utilize the antibacterial properties of silver, a new study in Advances in Skin and Wound Care suggests the only difference between silver dressings and a less expensive gauze dressing may be the cost. | Continue reading

7,433 reads | 1 comments | 11/19/2010
CPME Adopts Three-Year Residency Standard By Brian McCurdy, Senior Editor The Council on Podiatric Medical Education (CPME) recently approved residency changes that spell an end to the two- and three-year PM&S-24 and PM&S-36 programs. Starting July 1, 2011, podiatric residency programs will consist of a standard three-year Podiatric Medicine and Surgery Residency (PMSR) program. | Continue reading